Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. - de Jonge,E.; Dekkers,P.E.; Creasey,A.A.; Hack,C.E.; Paulson,S.K.; Karim,A.; Kesecioglu,J.; Levi,M.; van Deventer,S.J.; van der Poll,T. (Blood, 2000)